TheProfitWatch

MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.36 -0.51 (-4.92%) 0.0 (0.0%) -0.03 (-0.3%) -0.06 (-0.6%) -0.22 (-2.12%) -0.24 (-2.36%) 0.04 (0.39%) 0.04 (0.39%)

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.87
Diluted EPS:
-0.87
Basic P/E:
-11.3225
Diluted P/E:
-11.3225
RSI(14) 1m:
39.9
VWAP:
9.85
RVol:
0.5575

Events

Period Kind Movement Occurred At
1m Price increase 1m 9.78 +0.16 (+1.64%) Oct 15 10:37
1m Price decrease 1m 9.59 -0.1 (-1.02%) Oct 15 10:25
1m Price decrease 1m 9.93 -0.22 (-2.16%) Oct 15 09:30

Related News